Search Results 91-100 of 18208 for Hepatitis C

  1. Mayo Clinic Studies Identify Risk Factors in Rising Trend of Liver Cancer

    ... hepatitis C infection. "The liver scarring from hepatitis C can take 20 to 30 years to develop into cancer," Dr. Kim says. "We're now seeing cancer patients ...

  2. Telaprevir (oral route) - Mayo Clinic

    ... hepatitis C infection. These medicines are used in patients with liver disease (including cirrhosis) who have not been treated before or who have received ...

  3. The epigenome as a link between the environment and human disease - Research

    ... liver disease progression and hepatocellular carcinoma. The Epigenetic Etiology of Human Disease Laboratory studies the impact of hepatitis C virus infection on ...

  4. Autoimmune hepatitis - Diagnosis and treatment - Mayo Clinic

    This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.

  5. Cirrhosis Clinical Trials - Mayo Clinic Research

    A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults with Genotype 1b Chronic Hepatitis C Virus (HCV) Infection ...

  6. Identification of Chronic Hepatitis B Infections Among African and Asian Immigrants in Minnesota Through Community-Wide Screening - Mayo Clinic

    The prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in the United States (US) is relatively low. However, immigrant populations in the US ...

  7. Overview - Hepatobiliary Cancer Laboratory - Mayo Clinic Research

    The Hepatobiliary Cancer Lab of Lewis R. Roberts, M.B., Ch.B., Ph.D., at Mayo Clinic targets liver cancer genes and works to prevent hepatitis B and C ...

  8. Hepatitis A - Diagnosis and treatment - Mayo Clinic

    Hepatitis A is a contagious liver infection caused by a virus. Learn how the disease spreads and what you can do to prevent or treat it.

  9. STD testing: What's right for you? - Mayo Clinic

    Newly diagnosed hepatitis C infection; Having been in jail or prison; Men who have sex with men; Being pregnant or planning to become pregnant; Being forced to ...

  10. Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068) - Mayo Clinic

    Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 ...